FDA
-
-
-
-
-
-
-
RVL Pharmaceuticals plc Provides Business Update
-
-
-
-
-
-
-
RVL Pharmaceuticals (RVLP) Guides Q4 and FY22 Sales of UPNEEQ
-
-
-
-
-
-
-
RVL Pharmaceuticals plc to Present at the H.C. Wainwright 24th Annual Global Investment Conference
-
-
-
-
-
-
-
RVL Pharmaceuticals (RVLP) Reports Q2 Prelim Sales of $8.4M, Guides Q4 2022 Sales of $20M-$25M
-
-
-
-
-
-
-
RVL Pharmaceuticals (RVLP) Reports Prelim Q1 UPNEEQ Net Product Sales of $5.9M
-
-
-
-
-
-
322,220 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

